Eli Lilly (LLY) and Novo Nordisk (NVO) to dominate as TD Cowen lifts 2030 sales forecast for GLP-1 class of obesity/ diabetes ...
Real Housewives of New Jersey star Dolores Catania has reached her high school weight after two years on the medication. She ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends.
Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...
including obesity medicines. By the numbers, she was obese and hadn't been able to lose weight on her own. A nurse at the med spa offered her 16 weeks of compounded tirzepatide, which is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results